Robert Anthony Johnson - 11 Jul 2025 Form 4 Insider Report for DENTSPLY SIRONA Inc. (XRAY)

Signature
/s/ Jessica Causey, Attorney-In-Fact for Robert Anthony Johnson
Issuer symbol
XRAY
Transactions as of
11 Jul 2025
Transactions value $
$480
Form type
4
Filing time
15 Jul 2025, 16:45:17 UTC
Previous filing
15 Apr 2025
Next filing
15 Oct 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Johnson Robert Anthony SVP, Chief Supply Chain Office C/O DENTSPLY SIRONA INC, 13320-B BALLANTYNE CORPORATE PLACE, CHARLOTTE /s/ Jessica Causey, Attorney-In-Fact for Robert Anthony Johnson 15 Jul 2025 0001956855

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XRAY Common Stock Award $0 +755 +0.62% $0.00 123K 11 Jul 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XRAY Phantom Stock (Supplemental Executive Retirement Plan) SERP Award $480 +29.7 +0.99% $16.20 3.03K 11 Jul 2025 Common Stock 29.7 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.
F2 Includes 370 shares acquired between January 1st - June 30, 2025 under the Dentsply Sirona Employee Stock Purchase Plan.
F3 Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment.
F4 Comprised of phantom stock acquired as a result of accrued dividends.

Remarks:

Exhibit 24 - Power of Attorney